Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Inovio clinches $16.17m financing:

This article was originally published in Clinica

Executive Summary

Inovio Biomedical (San Diego, California) has secured $16.17m in the sale of common stock to institutional and accredited investors in Singapore and North America. The company, a specialist in drug delivery devices based on electroporation, sold around 4.6 million shares at $3.52 per share, in a bid to raise additional financing to fund the further development of its DNA delivery technology for gene-based therapies. The sale price represents an approximate 7% discount in comparison to Inovio's closing share price on the date of the definitive sales agreement (May 14).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT048711

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel